1. Long-term inhibition of ovulation by a GnRH-antagonist at low dose level.
- Author
-
Kovacs M, Mezo I, Flerko B, Teplan I, and Nikolics K
- Subjects
- Animals, Biological Assay, Drug Administration Schedule, Female, Gonadotropin-Releasing Hormone administration & dosage, Gonadotropin-Releasing Hormone chemical synthesis, Gonadotropin-Releasing Hormone pharmacology, Indicators and Reagents, Pregnancy, Proestrus drug effects, Rats, Gonadotropin-Releasing Hormone analogs & derivatives, Gonadotropin-Releasing Hormone antagonists & inhibitors, Ovulation drug effects
- Abstract
Ac-D-Trp1,3, D-Cpa2, D-Lys6, D-Ala10-GnRH has been prepared by solid phase synthesis. The peptide was found to completely inhibit ovulation when administered on proestrus day in a dose of 1.5 microgram/rat, s.c. The peptide completely inhibited ovulation for a period corresponding to three to four cycles when administered daily in a dose of 5 micrograms/rat, s.c. and caused 70% inhibition of ovulation in a dose of 3 micrograms/rat.
- Published
- 1984
- Full Text
- View/download PDF